To characterize the molecular phenotype of spermatogonial stem cells (SSCs), we examined genes that are differentially expressed in the stem/progenitor spermatogonia compared to nonstem spermatogonia. We isolated type A spermatogonia (stem and nonstem type A) from 6-day-old mice using sedimentation velocity at unit gravity and further selected the stem/progenitor cell subpopulation by magnetic activated cell sorting with an antibody to GDNF-receptor-alpha-1 (GFRA1). It has been previously shown that GFRA1 is expressed in SSCs and is required for their stemness. The purity of the isolated cells was approximately 95% to 99% as indicated by immunocytochemistry using anti-
INTRODUCTION
Spermatogenesis in mammals begins at puberty (5-7 days and 10-13 yr after birth in rodents and humans, respectively) and continues throughout life. Production of spermatozoa is a complex cell differentiation process that involves a wide repertoire of cell types residing in the testis. The process is initiated and maintained by a small population of spermatogonial stem cells (SSCs, 2-3 3 10 4 cells per adult mouse testis), attached to the basement membrane of the seminiferous tubules [1] . Spermatogonia have been recognized morphologically in whole mount preparations of seminiferous tubules from rodents, based on their clear cytoplasm, high nucleus-tocytoplasm ratio, and basal localization [2] . According to a well-established scheme of spermatogonial renewal, the Asingle (A s ) spermatogonia are the stem cells of spermatogenesis [3, 4] . A s spermatogonia are isolated cells that can divide into new A s stem cells or into differentiated A-paired (A pr ) spermatogonia that remain connected by an intercellular bridge. The A pr spermatogonia divide into chains of four Aaligned (A al ) spermatogonia that can divide further into chains of 8, 16 , and, rarely, 32 cells. The A al form A 1 to A 4 spermatogonia and then intermediate and type B spermatogonia and the primary spermatocytes. More recently, molecular and genetic studies of the seminiferous epithelium suggested the existence of two distinct populations of stem cells in the murine testis, the self-renewing ''actual'' SSCs and the ''potential'' SSCs that can be induced to self-renew in response to loss of ''actual'' SSCs [5, 6] . Furthermore, in Drosophila, it has been demonstrated that more differentiated spermatogonia can dedifferentiate to the spermatogonial stem cell [7] . There is major interest in studying the self-renewal and differentiation of SSCs since these cells give rise to sperm that carry the male genome from generation to generation. In addition, SSCs have recently been shown to reprogram spontaneously to pluripotent embryonic stem (ES)-like cells that can differentiate into a number of cell lineages comprising the three embryonic germ layers [8] [9] [10] .
A key step in studying the biology of SSCs is to determine their gene expression profile. Our knowledge regarding the molecular markers that characterize the SSCs was significantly limited during the past decades. The rarity of SSCs in the testis, the lack of unique surface markers, and the absence of an in vitro culture system to support their self-renewal have prevented the efficient isolation of SSCs with high purity for further study. Thus, for many years, the only means to evaluate the presence and function of SSCs has been the germ cell transplantation assay [11] . However, recently there has been significant progress toward the in vitro characterization of SSCs. Our group and others have demonstrated that glial cell-derived neurotrophic factor (GDNF) is the most essential factor for SSC self-renewal and maintenance in rodents [12] [13] [14] [15] [16] [17] [18] and that GDNF signals via binding to its membrane receptor complex containing GFRA1 and RET, both expressed by the spermatogonial stem/progenitor cells [19] [20] [21] [22] . Recent studies have suggested that GDNF signals via multiple pathways to promote the proliferation and self-renewal of SSCs [23] [24] [25] [26] [27] . Specifically, we have shown that GDNF acts through the RAS/ MAPK1/2 pathway, stimulating the phosphorylation of RET tyrosine kinase and finally inducing the transcription of the immediate early gene Fos as well as cyclin A and CDK2 protein expression. This enhances the S-phase entry of SSCs and induces their DNA synthesis and cell proliferation. Our group has also shown that GDNF activates the SRC family kinases (SRC, YES, LYN, FYN) and up-regulates MYCN through a phosphoinositide 3-kinase (PI3K)/AKT pathway in SSCs [25] .
The isolation of highly pure spermatogonial stem/progenitor cells (;95%) has contributed significantly to our increasing knowledge of GDNF signaling. The traditionally used method of sedimentation at unit gravity (STAPUT) [28, 29] for separation of spermatogonia has been complemented by our group with the magnetic activated cell sorting (MACS), using the antibody to GFRA1 receptor to purify the SSCs from 6-day-old mice [20] . Notably, another group using the same separation method in 10-day-old mice has demonstrated that the GFRA1-positive cells are able to induce spermatogenesis after transplantation into the testes of sterile mice, suggesting that these cells are enriched in SSCs in the testis [30] .
To provide novel molecular signatures for SSCs, we sought to compare the gene expression profiles of GFRA1-positive (enriched in SSCs) and GFRA1-negative cells (enriched in A pr and A al spermatogonia, the nonstem cell population) using microarray analysis. Further analysis of functional grouping and pathways was also performed to provide a basis for exploring the roles of signaling molecules and pathways in the regulation of the spermatogonial stem/progenitor cells. Since the expression change of Csf1r transcript is the most significant in GFRA1-positive cells compared to GFRA1-negative cells, we further probed the role of CSF1/CSF1R signaling in regulating the fate determinations of SSCs. Our results suggest that the CSF1/CSF1R signaling pathway plays a role in promoting the proliferation of the spermatogonial stem/ progenitor cells, which illustrates and confirms our pathway analysis of the microarray data.
MATERIALS AND METHODS

Isolation of Type A Spermatogonia from 6-Day-Old Mouse Testes
Male 6-day-old BALB/c mouse pups (Charles River Breeding Laboratories) were euthanized by carbon dioxide inhalation in accordance with the protocols approved by the Georgetown University Animal Care and Use Committee. Type A spermatogonia were isolated using the STAPUT method, which utilizes gravity sedimentation on a 2%-4% bovine serum albumin (BSA) gradient, as previously described [28, 29] . Briefly, the testes from 80 pups were decapsulated and minced in ice-cold DMEM-F12. Leydig cells, other interstitial cells, and peritubular myoid cells were eliminated by a first enzymatic digestion with collagenase IV (1 mg/ml) and DNase I (2 lg/ml) at 348C for 10 min and extensive washes with PBS to obtain only the seminiferous tubules. Germ cells and Sertoli cells were isolated by a second enzymatic digestion using collagenase IV (1 mg/ml), DNase I (2 lg/ml), hyaluronidase (1.5 mg/ml), and trypsin (1 mg/ml) under the same conditions. The resulting cell suspension, containing mainly type A spermatogonia and Sertoli cells, was subjected to gravity sedimentation for 2.5 h on a 2%-4% BSA gradient to separate type A spermatogonia from Sertoli cells. Type A spermatogonia were cultured for 2 h on fetal calf serum-coated dishes to further eliminate potential contamination of Sertoli cells by differential plating. This method allowed us to obtain type A spermatogonia with a purity of 90%-95%.
Separation of SSCs by MACS
Type A spermatogonia isolated by STAPUT were resuspended in 1 ml DMEM containing 10% NU serum (BD Biosciences) and incubated with 25 ll of rabbit anti-GFRA1 antibody (H-70, Santa Cruz Biotechnology) for 16 h at 48C with continuous rotation. The cells were washed three times with ice-cold PBS containing 0.5% BSA and 2 mM EDTA (wash buffer), and then they were resuspended in 80 ll of the wash buffer and incubated with 20 ll of goat antirabbit IgG MicroBeads (Miltenyi Biotech) for 20 min at 48C with rotation. The labeled cells were sorted through a separation MS column attached to a MiniMACS separator (Miltenyi Biotech). GFRA1-positive cells, the magnetically labeled cells, were retained within the column, whereas nonlabeled cells passed through and were collected as GFRA1-negative cell fraction. To increase the purity of the separation, the column was washed three times with 500 ll of wash buffer. In order to collect the GFRA1-positive cells, the column was removed from the magnetic separator, and 1 ml of wash buffer was added to the reservoir. GFRA1-positive and GFRA1-negative cells were counted on a hematocytometer and used immediately for RNA isolation. Typically, we were using 80 pups per experiment, and the number of GFRA1-positive cells was ;60 000, with a purity of 95%-99%, as determined by immunostaining. Two independent cell isolation experiments were performed.
RNA Isolation
Total RNA was extracted from the cells using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. The RNA samples were treated with RNAse-free Dnase I (Qiagen) to remove traces of genomic DNA. The concentration and quality of total RNA was determined using the NanoDrop-1000 Spectrophotometer. A typical RNA isolation would yield 500 ng and 2 lg of total RNA from GFRA1-positive and GFRA1-negative cells, respectively, and good quality RNA samples (OD 260 1.8-2.0) were used for cDNA synthesis.
Complimentary DNA Synthesis and Target Preparation cDNA was synthesized from 30 ng total RNA and amplified using the Ovation Biotin RNA Amplification and Labeling System, version 1.0 (NuGEN Technologies, catalog no. 2300-12). The amplified cDNAs were purified using the Zymo Research Clean and Concentrator-25 columns and, subsequently, fragmented and biotin labeled using the reagents of the Ovation system. The biotin-labeled and -fragmented cDNAs were purified using the QIAGEN DyeEx 2.0 Spin kit (Qiagen, catalog no. 63204). Finally, their yield and purity were measured by absorbance at 260, 280, and 320 nm. Only cDNA samples showing an OD 260 -OD 320 /OD 280 -OD 320 ratio higher than 1.8 were used for microarray hybridization.
Hybridization on Mouse Genome 430 v.2 cDNA Arrays (Affymetrix)
Each of the arrays used contains over 39 000 mouse transcripts. Each of the transcripts is represented on the array by multiple probes to ensure the maximum accuracy and reproducibility of the hybridization results. The sequences from which these probe sets were derived were selected from GenBank, dbEST, and RefSeq. The sequence clusters were created from the UniGene database (Build 107, June 2002) and then refined by analysis and comparison with the publicly available draft assembly of the mouse genome from the Whitehead Institute for Genome Research (MGSC, April 2002). The Affymetrix protocol for eukaryotic sample and array processing (www. affymetrix.com/support/technical/manual/expression_manual.affx) was followed for the staining, washing, and scanning of the arrays. Briefly, the fragmented cDNA probe (0.011 lg/ll) was mixed with 50 pM of the control oligonucleotide B2 and 1.5, 5, 25, and 100 pM of each of the eukaryotic hybridization controls (bioB, bioC, bioD, and cre, respectively). Herring sperm DNA (0.1 mg/ml), BSA (0.5 mg/ml), 10% DMSO, and 13 hybridization buffer were also added in a total volume of 200 ll (49 format array), and the mix was heated to 998C for 5 min before it was applied to the arrays, which had been prehybridized with 13 hybridization buffer for 10 min at 458C. The hybridization was performed for 16 h at 458C with 60-rpm rotation. Arrays were washed on Affymetrix's GeneChip Fluidics Station 450 using a primary streptavidin phycoerythrin (SAPE) stain, subsequent biotinylated antibody stain, and secondary SAPE stain, following the EukGE-WS2v5 protocol. Arrays were scanned on Affymetrix's GeneChip Scanner 3000 7G with 708 AutoLoader. Scanned images obtained by the Affymetrix GeneChip Operating Software (GCOS) v1.4 were used to extract raw signal intensity values per probe set on the array and calculate detection calls (absent, marginal, or present). All raw chip data were scaled in GCOS to normalize signal intensities for interarray comparisons. In total we used four arrays for the duplicate GFRA1-positive and GFRA1-negative samples.
Statistical Analysis
Raw signal intensity and detection call data obtained per array from GCOS were uploaded into Partek Genomics Suite software (Partek Inc.) for statistical analysis. The t-tests were applied to locate genes whose expression levels are statistically significant in differentiating expression between GFRA1-positive and GFRA1-negative cells populations. For each cell population, genes that had a maximum P-value ,0.05 and false discovery rate ,0.01 were collected. From these gene lists, those genes that showed consistent fold changes above a minimum threshold (.2-fold increase or decrease) were identified as ''differentially expressed'' between the two cell populations. For the pathway analysis we also used the genes that were moderately overexpressed in the GFRA1-positive cells (1.1-1.9-fold change) compared to GFRA1-negative cells. To check the overall general trends of expression over the two cell populations and compare the results of the two different experiments for each cell population, principal components analysis (PCA) was performed. This analysis converts a multidimensional data set into a set with fewer dimensions by using a covariance matrix but also retains the variability in the data in doing so. Thus, PCA characterized the major patterns of differential expression across the cell populations that account for variability in the data.
Pathway Analysis
Lists of the genes with changes in level of expression in the range between 1.1-fold and .2-fold, in the form of Excel sheets, containing gene identifiers and corresponding expression values were uploaded into Ingenuity Pathways Analysis (Ingenuity Systems, www.ingenuity.com) to identify relationships between the genes of interest and to uncover common processes and pathways in the GFRA1-positive cells. Each gene identifier was mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base. Networks of the genes were then algorithmically generated based on their connectivity. The ''Functional Analysis'' tool of IPA software was used to identify the biological functions that were most significant to the data set. Canonical pathways analysis was also utilized to identify the pathways from the Ingenuity Pathways Analysis library of canonical pathways that were most significant to the data set. Fishers exact test was used to calculate a P-value determining the probability that each biological function or canonical pathway assigned to the data set is due to chance alone. In addition, significance of the association between the data set and the canonical pathway was calculated as a ratio of the number of genes from the data set that map to the pathway divided by the total number of genes that map to the canonical pathway. The ''Pathway Designer'' tool of the IPA software was used for the graphical representation of the molecular relationships between gene products. Gene products are represented as nodes, and the biological relationship between two nodes is represented as an edge (line). All edges are supported by at least one reference from the literature, from a textbook, or from canonical information stored in the Ingenuity Pathways Knowledge Base.
RT-PCR
For the semiquantitative RT-PCR analyses, the SuperScript III First-Strand Synthesis System (Invitrogen) was used to perform reverse transcription with 500 ng of the oligo-dT primer and 25 ng of total RNA from GFRA1-positive and GFRA1-negative germ cells isolated from 6-day-old mouse testes. Total RNA from the C18-4 spermatogonial cell line [31] was also used to check the presence of the analyzed transcripts. Reactions were performed in duplicates; RT enzyme was added in one of the two, the other serving as a negative control for the presence of genomic DNA in the samples. PCR was performed with the PCR Master mix (Roche) using 10% of the RT reaction as a template. To obtain semiquantitative results, only 31 three-step amplification cycles were used, and the final extension step was omitted. The primer sequences of the chosen genes were shown in Supplemental Table 1 (all supplemental data are available online at www.biolreprod.org).
Immunostaining
Small fraction of cells (500-1000 cells/slide) were attached on microscope slides using the Cell Adherence Solution (Crystalgene), fixed with 4% paraformaldehyde, and stored at 48C until they were used for immunocytochemistry. Immunostaining of the isolated spermatogonia, the C18-4 cell line or paraffin embedded testis sections was performed as described previously [21] . The cells or tissue sections were blocked with 5% normal serum in 13 PBS and 0.1% Tween 20 for 30 min or 1 h. The primary antibodies, including goat anti-GFRA1 (Santa Cruz Biotechnology), rabbit anti-CSF1R (Abcam), and mouse anti-BrdU (Sigma), were diluted at 1:100 in 13 PBS containing 1% BSA and 0.1% Tween-20 and incubated at 48C for 12 h. The fluorescent conjugated secondary antibodies (donkey anti-goat FITC, donkey anti-goat TRITC, donkey anti-rabbit TRITC, or donkey anti-mouse FITC) were all purchased from Jackson Immunoresearch, diluted 1:250 in 13 PBS containing 1% BSA and 0.1% Tween-20, and incubated at room temperature for 1 h. Nuclei were stained either fluorescently with DAPI or with hematoxylin. Immunohistochemistry with the anti-CSF1R and anti-BrdU antibodies was performed using the HistoPlus kit (Zymed) according to the manufacturer's protocol. Treatment of the cells for anti-BrdU staining was carried out pursuant to the manufacturer's protocol (Sigma), without the trypsin digest.
BrdU Incorporation Assays
To test the effect of macrophage colony-stimulating factor (CSF1) on the proliferation of the C18-4 spermatogonial stem cell line, we plated C18-4 cells on glass coverslips in three wells of a six-well cell culture dish (5000 cells/well) in DMEM supplemented with 10% FBS for 4 h at 348C with an atmosphere of 5% CO 2 and then changed to serum-free DMEM at the same conditions for 24 h. Recombinant mouse CSF1 (R&D Systems) was added on wells 1 and 3 at a concentration of 1 ng/ml, while well 2 was left untreated. BrdU (30 lg/ml, from SPERMATOGONIAL STEM/PROGENITOR CELL TRANSCRIPTOME Sigma) was added in wells 2 and 3, not in well 1. The cells were incubated for 24 h before staining with anti-BrdU. Stained nuclei were counted from 20 randomly selected fields of view, each containing approximately 100 cells, under the 203 objective. The experiment was repeated three times. To test the effect of CSF1 on type A spermatogonia, we isolated the spermatogonia from the testes of 24 6-day-old mice as described previously, cultured them in three wells of a 12-well dish (4000 cells/well) in serum-free DMEM for 48 h, and then added CSF1 and/or BrdU, as described for the C18-4 cells. The spermatogonia were incubated for 24 h, then collected in a 1.5-ml tube, spun down, resuspended in Cell Adherence Solution (Crystalgene), and allowed to attach on glass slides for immunostaining with anti-BrdU. Stained nuclei were counted as described previously. The experiment was repeated twice.
RESULTS
Highly Enriched GFRA1-Positive Cells and GFRA1-Negative Cells by MACS Using Anti-GFRA1
Using the STAPUT procedure, we collected 90-100 fractions (10 ml each) and examined them under the microscope to determine which fractions were highly enriched (.90%) in spermatogonia. Spermatogonia, characterized by their round shape, clear cytoplasm, and a diameter of 14-16 lm were collected in fractions 36-50 (Fig. 1a) . Besides the spermatogonia, the main cell type in the seminiferous epithelium of the 6-day-old mice is the Sertoli cell. Sertoli cells are easily distinguished from the spermatogonia (Fig. 1b) because of their smaller size (diameter of 8 lm), their irregular and granular appearance, dense chromatin, and prominent nucleoli. Sertoli cells were observed in later fractions (66-76). A small percentage of contaminating cells (2%-5%) that was observed in our spermatogonial isolations was probably from cell aggregates that formed in the BSA gradient. Optimizing the enzymatic digestion conditions minimized this problem. In addition, contaminating Sertoli and myoid cells were further eliminated by differential plating (see Materials and Methods) after STAPUT. After MACS with anti-GFRA1, the morphology of the GFRA1-positive cells (Fig. 1c) and the GFRA1-negative cells was similar to that of the spermatogonia cell population isolated by STAPUT (Fig. 1a) . However, the molecular phenotype of these two cell populations is obviously distinct. Immunocytochemical analysis showed that 95%-99% of the positive cell fraction was stained for GFRA1 (Fig. 2, a  and b) , whereas less than 5% of the negative cell fraction was positive for GFRA1 (Fig. 2, c and d) . In a typical experiment, we obtained 8 3 10
6 spermatogonia from 160 testes of 6-day- old mice by STAPUT, and 0.8% (0.06 3 10 6 ) were GFRA1-positive cells after MACS.
Comparison of the Gene Expression Profiles of GFRA1-Positive and GFRA1-Negative Cells by Microarray Analysis
Evaluation of the microarray experiments. The reproducibility and accuracy of our microarray experiments were initially assayed. Both PCA mapping and signal scatter plots of our data (Fig. 3) indicate that the two cell populations compared (GFRA1-positive vs. GFRA1-negative cells) have the majority of their expressed genes in common, as shown by the high concentration of signal intensity dots along the diagonal line of the scatter graph. This is an expected observation since both populations are spermatogonia and should differ mostly in the expression of genes related to the stem-cell function of GFRA1-positive cells. The distribution of differentially expressed genes is also shown in Figure 3b . In most cases, the level of their transcripts shows a fold change in the range of 2-33, but there are also higher fold changes, ranging from 103 to .303. In addition, these statistical assays showed that our experiment was reproducible. As shown by the PCA map (Fig. 3a) , the duplicate GFRA1-positive experiments are closer to each other than to the GFRA1- negative   FIG. 4 . Validation of the representative genes of microarray data by semiquantitative RT-PCR. a) Semiquantitative RT-PCR shows the mRNA expression of Csf1r, Ccl7, Ccl9, and Bmp2 in GFRA1-positive and GFRA1-negative cells from testes of 6-dayold mice after MACS. Mouse genomic DNA was used as a positive control for PCR, and no template served as a negative control. Gapdh served as a loading control for total RNA. b) The mRNA expression of five representative genes was assayed by RT-PCR of the spermatogonial derived cell line C18-4. ctrl, control; w/o, without. SPERMATOGONIAL STEM/PROGENITOR CELL TRANSCRIPTOME experiments. Also, the scatter graphs comparing the signal intensity distribution of the two different repeats show similar results. In addition, we were able to detect several genes that are known to be expressed in spermatogonia or were found in other microarray experiments performed by different groups with various testicular cell populations (see Discussion). The accuracy of our microarray results was also confirmed experimentally by semiquantitative RT-PCR of representative genes that were found to be overexpressed in GFRA1-positive cells according to the microarray data. All the genes that were checked were detected in the GFRA1-positive cell population (Fig. 4a ). Furthermore, we tested the expression of representative genes in the spermatogonial-derived cell line C18-4 [31] and found that three of them (Csf1r, chemokine [C-C] ligand 9 Ccl9, and Gfra1) are expressed in the cell line, while two mRNAs (bone morphogenetic protein 2 Bmp2 and chemokine [C-C] ligand 7 Ccl7) could not be detected (Fig. 4b) .
Differentially expressed genes between the GFRA1-positive and GFRA1-negative cells. Using microarray analysis, we found that 639 transcripts (621 unique), representing ;1.6% of the total number of transcripts on the Genechip microarray platform, were differentially expressed between the GFRA1-positive and GFRA1-negative cells. Specifically, we detected 373 (361 unique) known genes and 77 uncharacterized transcripts that were overexpressed in the GFRA1-positive cells. Among them, 99 of the known genes and 12 uncharacterized transcripts were increased by more than 2-fold, while the others were moderately increased (1.1-1.9-fold). On the other hand, 162 (156 unique) known genes and 27 uncharacterized transcripts were underexpressed in the GFRA1-positive cells. Among the underexpressed genes, 54 of the known genes and 14 of the uncharacterized ones were reduced with .2-fold decrease in their mRNA levels. The first 20 genes that were found to be overexpressed or downexpressed with the highest fold changes in the GFRA1-positive cells compared to GFRA1-negative cells are summarized in Tables 1 and 2 , respectively. The gene encoding colonystimulating factor 1 receptor (Csf1r) was overexpressed in the GFRA1-positive cells with the highest fold change (36.663), whereas the gene encoding LIM homeobox 8 protein (Lhx8) was underexpressed in the GFRA1-positive cells with the highest fold change (À15.713). A complete list of all the differentially expressed genes and uncharacterized transcripts identified by this microarray can be found in Supplemental Tables 2-5 .
Functions, Networks, and Pathways
We used the Ingenuity Pathway Analysis (IPA) software for the functional grouping of the genes that are overexpressed in GFRA1-positive cells and to determine the main functions and signaling pathways implicated in these cells. We uploaded FIG. 5 . Analysis of the microarray data with the Ingenuity Pathways software. a) Functional grouping of the genes that were overexpressed in the GFRA1-positive cells. The most significant functional groups, with Pvalues ,0.05, are presented graphically. The bars represent the P-value in logarithmic scale for each functional group. For a complete list of the genes assigned to these functions, see Supplemental Table 6 . b) The eight most prominent canonical pathways related to our data set with P-values ,0.05. The bars represent the P-value for each pathway. The orange irregular line is a graph of the ratio (genes from the data set/total number of genes involved in the pathway) for the different pathways. The genes from our data set involved in these pathways are presented in Supplemental Table 7 . c) An example of a network, showing the relationships between eight molecules (highlighted in blue) identified by the microarray and overexpressed in GFRA1-positive cells. The type of the association 3 between two molecules is shown as a letter on the line that connects them. The number in parenthesis next to the letter represents the number of bibliographic references currently available in the Ingenuity Pathways Knowledge Base that support each one of the relationships. Direct or indirect relationships between molecules are indicated by solid or dashed connecting lines, respectively. Molecules labeled in red are the ones that showed .2-fold of increase in the GFRA1-positive cells, while the molecules in pink showed a 1.1-1.9-fold change. The asterisks indicate the molecules that are represented more than once in our data set. P, phosphorylation; A, gene activation; E, increase in expression; PP, proteinprotein interaction; PD, protein-DNA binding; MB, membership in complex.
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an Excel sheet containing the Affymetrix ID, GenBank gene symbol, gene description, P-value, and fold change for the 361 unique known overexpressed genes. We found that 250 of these genes could be assigned to a specific functional group based on the information in the IPA Knowledge Base. We observed that 98 of the mapped genes, representing about 40% of the total, were classified under the functional group ''Cancer,'' which contains genes involved in tumorigenesis, invasion, migration, and growth of tumors. Other functional groups, including cellular movement, growth and proliferation, cell cycle, cell signaling, and embryonic development, were also observed. A graphical representation of this functional classification of the genes overexpressed in GFRA1-positive cells is shown in Figure 5a , in which the 10 functional groups with higher P-values are noted. Some of these groups shared several common genes. The genes classified into each of these groups are listed in Supplemental Table 6 . In addition, the IPA software assigned 29 of the genes in our data set to eight different canonical pathways. Each pathway consisted of a total of 93-391 genes and involved 5-15 genes that were overexpressed in the GFRA1-positive cells. The eight selected pathways had ratios ranging from 5% to 7% and P-values lower than 0.05 (Fig. 5b) . The genes assigned to these signaling pathways are presented in Supplemental Table  7 . Finally, the genes in our data set were mapped on 17 networks, each containing 12-27 genes from the input data that shared known direct or indirect relationships. An example of a network created from our data is shown in Figure 5c , where the relationships between molecules that were overexpressed in GFRA1-positive cells (CSF1R, GFRA1, BMP2, COL1A2, FYN, PIK3, AKT3, PIK3CA, POU5F1, CCNH, NR5A2) are represented by the arrows that connect them. This is part of a more complex network that leads to cell proliferation through the activation of mitogen-activated protein kinase (MAPK).
Csf1r Is Expressed in the Spermatogonia of the 6-Day-Old Mice
Expression of Csf1r gene was detected at the mRNA level in the GFRA1-positive cells by microarray and was verified by RT-PCR in the GFRA1-positive cells and in the C18-4 cell line (Fig. 4) . We also detected CSF1R protein with anti-CSF1R on paraffin sections of 6-day-old mouse testes. Immunohistochemistry showed that CSF1R protein was expressed at the periphery of spermatogonia along the basement membrane of SPERMATOGONIAL STEM/PROGENITOR CELL TRANSCRIPTOME the seminiferous tubules (Fig. 6, a and b) . In contrast, Sertoli cells characterized by their oblong nucleus were unstained for this protein (Fig. 6a) . Notably, double staining, using goat anti-GFRA1 and rabbit anti-CSF1R, revealed the coexpression of CSF1R and GFRA1 proteins in GFRA1-positive cells purified from 6-day-old mouse testes by MACS using rabbit anti-GFRA1 (Fig. 6, c-e) . The GFRA1-negative cells did not stain with anti-CSF1R when the double staining was performed on the unsorted spermatogonia of 6-day-old mice ( Fig. 6, f-h) . Thus, the combined gene expression and immunohistochemistry results suggest that Csf1r is expressed in spermatogonia, specifically in GFRA1-positive cells of the 6-day-old mouse testes.
CSF1 Promotes Proliferation of Spermatogonia
Since Csf1r was the predominant gene overexpressed in the GFRA1-positive cells, we examined whether its ligand CSF1 could have an effect on the proliferation of spermatogonia in culture. To determine the role of CSF1 in DNA synthesis of spermatogonia, we performed the BrdU incorporation assay. We used both the spermatogonial derived cell line C18-4 [31] and freshly isolated spermatogonia from 6-day-old mice. Approximately 2000 cells were counted after BrdU staining in each experiment, and the assay was repeated three times on the C18-4 cells and two times on the primary spermatogonial culture. In both cell types, the addition of 1 ng/ml CSF1 to the culture was able to induce cell proliferation, as shown by the significant increase in the percentage of BrdU-positive cells ( Fig. 7) from ;30% to ;80% (for the C18-4 cells) or ;70% (for the primary culture). The data for the statistical analysis represented by the graphs in Figure 7 , d and i, are shown in Supplemental Table 8 .
DISCUSSION
In the current study, we have successfully isolated a highly purified population of GFRA1-positive cells (enriched in SSCs) and analyzed their gene expression profile, aiming to provide novel insights on the molecules that are specifically expressed and that can be used as additional markers for the stem/progenitor cell isolation and identification and for a better understanding of their functions. Statistical and experimental evaluation of our microarray data showed that the experiment was both accurate and reproducible. We identified 621 unique mRNAs as differentially expressed between GFRA1-positive and GFRA1-negative cells in the testes of the 6-day-old mice. Three hundred and sixty-one known genes were overexpressed and 156 down-expressed in the GFRA1-positive cell population. Among these gene transcripts, 99 known genes were overexpressed in the GFRA1-positive cells with an increase of .2-fold change in their expression levels. Although this is generally considered the cutoff to determine the differentially expressed genes for typical microarray experiments, where large changes in gene expression are expected, in the case of spermatogonial stem/progenitor cells we decided to also include the genes that were overexpressed with smaller fold changes (1.1-1.9) and had a P-value ,0.05 in our analyses. This permits greater sensitivity and the detection of small but significant changes in gene expression between the subpopulations of GFRA1-positive and GFRA1-negative spermatogonia that may reflect their different functions.
Interestingly, we were able to identify a number of genes that had been previously shown to be expressed in spermatogonia by other means and experimental settings. For example, in a recent study performed by our group [32] , we analyzed the mouse germ-cell transcriptome at different phases of spermatogenesis (spermatogonia, spermatocytes, and spermatids) 714 by serial analysis of gene expression and identified two of the genes that are present in our current microarray data as overexpressed in GFRA1-positive cells: procollagen type I alpha 2, (Col1a2) and malate dehydrogenase 1B (Mdh1b). Using microarray analysis, our laboratory has also recently shown that Col1a2 is among the most abundant gene transcripts in the seminiferous tubules of immature mice compared to adult mice [33] . In addition, we observed a partial overlap between our data and the results of other microarray experiments performed on spermatogonia isolated by STAPUT [34, 35] (see Supplemental Text 1). The main reason that accounts for this partial overlap is that we are focusing on the genes that are differentially expressed between GFRA1-positive (enriched in SSCs) and GFRA1-negative cells, a subset of the genes that are expressed in the total type A spermatogonial population. However, there is an overlap between our results and the microarray results of Orwig and colleagues [36] , who have analyzed the transcriptome of whole testes cell suspensions from wild-type, cryptorchid, and busulfan-treated animals and, using a substractive method, have determined a stem/progenitor gene cluster that consists of 88 genes expressed in spermatogonial progenitors and not expressed in differentiated germ cells or somatic cells. Seven of these genes (cell division cycle-associated 7, Cdca7; chemokine [C-C] ligand 7, Ccl7; procollagen type XVIII alpha 1, Col18a1; Sloan-Kettering viral oncogene, Ski; tyrosine protein kinase binding protein, Tyrobp; melanoma cell adhesion molecule, Mcam; and H2A histone family member V, H2afv) are also found in our microarray data to be overexpressed in the GFRA1-positive cells. In addition, in a gene expression study of cultured SSCs in the presence or absence of GDNF [37] , the genes encoding the LIM homeobox protein 1 (Lhx1) and the Bcell lymphoma protein 6b (Bcl6b) were two of the five that were affected by GDNF and thus are important for the selfrenewal and survival of SSCs. Both of them are overexpressed in the GFRA1-positive cells of the 6-day-old mice, based on our microarray data.
Since the GFRA1-positive cells are believed to be highly enriched in spermatogonial stem cells [19] [20] [21] [22] 30] , we expect their gene expression profile to overlap with the transcriptome of other types of stem cells. Two major gene expression studies of stem cells have been published so far [38, 39] . They both independently compared the gene expression profiles of mouse adult hematopoietic and neural stem cells with mouse embryonic stem cells. Ivanova and colleagues have also compared the transcriptomes of mouse and human hematopoietic stem cells to define key conserved regulatory pathways [39] . Each of these studies has determined a list of approximately 200 genes that potentially comprise the molecular signature of stem cells. Comparison of our microarray data with their results revealed an overlap of 34 genes that are overexpressed in GFRA1-positive cells and are also defined as ''stem cell genes'' by these studies (Table 3) . This is probably an underestimate of the overlap because we did not include their unknown cDNAs in the comparison, and it is reasonable considering the fact that we are comparing a different type of stem cell and also that the common genes identified by both of these studies were only 15. This lack of extended similarity between them probably reflects the differences in the method used for the isolation of the stem cell populations, in the design of the hybridization experiments, and in the computational algorithms used to measure changes in gene expression [40] . However, it is noteworthy that several of our most prominently overexpressed in GFRA1-positive cells genes (e.g., Csf1r, Tyrobp, Cd53, Col18a1) are included in the ''stem cell'' gene list (Table 3) . Finally, the gene encoding the POU domain containing class 5 transcription factor 1 (Pou5f1, previously known as Oct4), a wellestablished embryonic and adult stem cell marker, is among the overexpressed genes in the GFRA1-positive cells. This finding is supported by our previous studies in which we have demonstrated that a subpopulation of the spermatogonia in the immature mouse testis coexpress GFRA1 and POU5F1 [21] .
The assignment of the genes overexpressed in GFRA1-positive cells to different functional groups, depending on the signaling pathways they have been mapped to, gives us important clues for the functions that are characteristic for the SSCs. Based on our data, there appear to be two main biological processes taking place in the stem/progenitor cells: 1) cell survival and proliferation and 2) cytoskeletal reorganization for cell migration or docking on the basement membrane of the seminiferous tubules. Genes mapped to pathways such as the insulin-like growth factor 1 (IGF1) signaling (Igfbp5, Irs1), the PI3K/AKT signaling (proto-oncogene Akt3, B-cell lymphoma gene Bcl2), the mitogen-activated protein and Jun kinases (MAPK/JNK) signaling (Irs1), and the oxidative stress response (glutathione S-transferases alpha 4 and m1, Gsta4 and Gstm1) are overexpressed in the GFRA1-positive cells and may be responsible for their survival and proliferation. Pathways such as the axonal guidance and ephrin receptor signaling result in both cell proliferation and cytoskeletal SPERMATOGONIAL STEM/PROGENITOR CELL TRANSCRIPTOME changes and in the GFRA1-positive cells may be mediated primarily by the expression of the overexpressed genes encoding the ephrin receptors A2 and B1 (Epha2, Ephb1). Furthermore, the GFRA1-positive cells express molecules such as the bone morphogenetic protein 2 (BMP2) and the tyrosine kinase binding protein (TYROBP), which function through various signaling pathways (Fig. 5c ), mediating both cell proliferation and cytoskeletal changes. It is essential to emphasize, however, that before assaying the role of any of the molecules identified by microarray in SSCs, it is necessary to verify its presence in SSCs by other means, such as by immunohistochemistry.
The most prominent transcript overexpressed in GFRA1-positive cells by 363 was the one encoded by the colonystimulating factor 1 receptor gene (Csf1r). The role of the ligand CSF1 and its receptor Csf1r on the SSCs has not yet been studied. However, there is evidence for the role of the granulocyte macrophage colony-stimulating factor (GM-CSF, official symbol CSF2) in the testis; our group has previously reported that CSF2 enhances the survival of porcine type A spermatogonia [41] , and others have demonstrated the expression of CSF2 in male porcine differentiated germ cells [42] . CSF1 acts through the CSF1R receptor, encoded by the c-fms proto-oncogene, which has been shown to be transcriptionally active in both hematopoietic and nonhematopoietic tissues, such as placental trophoblasts, endothelial cells, oligodendrocytes of the central nervous system, follicular fluid, ovarian cells, and fallopian tube cells. CSF1R protein has been detected in various types of stem/progenitor cells, such as the primitive multipotent hematopoietic cells [43] , mononuclear phagocyte progenitor cells [44] , and monoblasts [45] . Csf1r mRNA has been also detected in the female reproductive tract, in oocytes and embryonic cells of the inner cell mass and trophectoderm, and in cells of the trophoblast [46] . CSF1 has been shown to promote the proliferation and differentiation of progenitor hematopoietic stem cells [43] and the clonogenic growth of murine colonic crypt epithelial cells in vitro [47] . Here, detecting both the mRNA and the protein gene products, we show for the first time that the CSF1R receptor is also expressed in spermatogonia and specifically in GFRA1-positive cells of the 6-day-old mice that are highly enriched in spermatogonial stem/progenitor cells. We also demonstrate that CSF1 promotes the proliferation of C18-4 cells and freshly isolated type A spermatogonia as shown by BrdU incorporation assays. Since CSF1R is expressed in GFRA1-positive cells, we suggest that CSF1 promotes the proliferation of these cells only. These results, showing the action of CSF1 and its receptor CSF1R in stem/progenitor cells, illustrate the analysis of our microarray data with the IPA software (Fig. 5c ). This analysis suggests that both CSF1R and GFRA1 can trigger the protein phosphorylation cascades in the MAPK pathway that leads to cell proliferation. Evidence for this comes from our work with GFRA1 [23] and also from studies of the effect of CSF1 on cancer cell lines, where it was shown that transfection of glioblastoma cells with the v-Fms oncogene increases their survival and proliferation via mitogenic pathways [48] . There is also evidence that the expression of both receptors (CSF1R and GFRA1) is regulated by BMP2. Experiments performed in a mouse osteoblast cell line [49] and in the developing rat sympathetic neurons [50] have shown that BMP2 increases the expression of CSF1R and GFRA1, respectively. Since the proliferative effect of BMP2 has been demonstrated in mouse spermatogonia [51] , the previously mentioned pathway models should be further investigated and tested in the SSCs. The analysis of our microarray data with the IPA software also revealed a functional connection between POU5F1, cyclin H (CCNH), and the member 2 of the subfamily 5 of nuclear receptors (NR5A2), which may occur in spermatogonial stem cells, contributing to their ''stemness.'' Indeed, POU5F1 has been found to bind on the same promoter sequence as NR5A2 by chromatin immunoprecipitation assays in undifferentiated mouse embryonic stem cells [52] , while in vitro kinase assays have shown that a complex consisting of CCNH and the cyclin-dependent kinase 7 (CDK7) promotes the phosphorylation of POU5F1 [53] .
In conclusion, we have identified a number of transcriptional signatures in GFRA1-positive cells, the spermatogonial stem/ progenitor cells, of the 6-day-old mouse testis. This study thus provides novel insights into the molecular characteristics of stem/progenitor cells in the testis and lays a basis for functional analysis of these signaling molecules and pathways in the SSCs. Certain gene transcripts identified by us have been detected previously by others in SSCs and in other types of stem cells. Therefore, we are also aiding the efforts to describe the set of genes that are required for ''stemness'' in different tissues. Moreover, we illustrated the role of CSF1/ CSF1R signaling in promoting cell proliferation of spermatogonia in vitro.
